Professional Documents
Culture Documents
Cucunawangsih
2013
CLASSIFICATION
RNA
Non-enveloped
Enveloped
Non-enveloped Enveloped icosahedral
Icosahedral
Caliciviridae
Hepadnaviridae
Flaviviridae
HEPATITIS E
HEPATITIS B
HEPATITIS C
Picorviridae
Hepatitis
Antigen Corresponding Ab Comments
type
RNA virus; present in stool and serum early in
A Hepatitis A virus (HAV) Anti-HAV
course of hepatitis A
DNA virus; found in serum in > 90% of patients
Hepatitis B surface
Anti-HBs with acute hepatitis B; anti-HBs appears after
antigen (HBsAg)
infection and confers immunity
B Hepatitis B core antigen Anti-HBc detected in serum during and after
Anti-HBc
(HBcAg) acute infection
Hepatitis B envelope HBeAg correlates with infectivity; suggestive of
Anti-HBe
antigen (HBeAg) active viral replication
RNA virus; previously known as posttransfusion
C Hepatitis C antigen Anti-HCV
NANB hepatitis
D Hepatitis D antigen Anti-HDV Defective RNA virus; requires presence of HBsAg
RNA virus present in stool; cause enteric NANB
E Hepatitis E antigen Anti-HEV
hepatitis
Applied Therapeutics; ed.20; Koda-Kimble&Young
TRANSMISSION
Mode of transmission
Injection,
heterosexual
Fecal/oral
and homosexual sex
Store at:
• 25 0 C with 42% relative humidity 1 month
• -200C years
Destroyed by:
autoclave (1210C, 20’), boiling 5’, dry heat (1800C, 1 hour),
UV 1.1 watts(1’), formalin 1:1000 (3 days, 370C),
chlorine 10-15 ppm (30’)
Envelope None
Replication Cytoplasm
Variation One serotype
PATHOGENESIS
HAV tertelan, replikasi terjadi di mukosa usus diikuti periode
viremia masuk hepatosit
IgM anti-HAV:
IgM class antibody to HAV
indicates recent infection with
hepatitis A positive up to 4-6 month
after infection
PREVENTION IMMUNOPROPHYLAXIS
PASSIVE: Vaccine
Single (Havrix/Vaqta)
Combination (Twinrix) 18 years or older
HEPATITIS B VIRUS
Stable:
• 370C for 60 minutes
• 260C 1 week
• -200C 20 years
• HBsAg stable at pH 2,4 for up to 6 hours,
but HBV infectivity is lost
Composition DNA
Double-stranded DNA, circular, 3.2 kb in size,
infectious, negative sense is full length and positive
Genome
sense is partially complete. The gap must be
complete at beginning of replication cycle
Two major polypeptides are present in HBsAg; one
Proteins
polypeptide is present in HBcAg
Envelope Contain HBsAg and lipid
In vivo replication: liver, lymphocytes, pancreas,
other organs.
Replication HBcAg in nucleus; HBsAg in cytoplasm; both mature
virus and 22 spherical particles consist of HBsAg
secreted from the cell surface
Genom of Hepadnavirus (Hepatitis B Virus)
Nucleic acid
Capsid
Envelope
Akut
Kronis
Window period
During the incubation period, HBsAg and HBeAg are the first indicators of HBV infection in the
blood
In some people with acute infections, HBsAg become undetectable before anti-HBs appear.
This is “window period”, during which a person tested for HBsAg and Anti-HBs will appear
uninfected.
Anti HBe and Anti HBs do not appear until the beginning convalescence
CHRONIC INFECTION
The continued presence of HBsAg beyond six months and the absence of
anti-HBs is an indication that infection has become chronic
Common Serologic Patterns of Hepatitis B Virus Infection
HBsAg HBeAg Anti-HBs Anti-Hbe Anti-HBc Interpretation
+ + - - - Incubation period
Acute HBV infection (typical
+ + - - + (IgM) case); chronic HBV carrier with
high infectivity
- - + - + (IgG) Recovery from HBV infection
Chronic HBV carrier; chronic
+ - - - + (IgG)
hepatitis B
Successful immunization with
- - + - -
HBV vaccine
Applied Therapeutics; ed.20; Koda-Kimble&Young
HBsAg PREVALENCE
DIAGNOSIS LABORATORIUM
Classification Flaviviridae
Composition RNA
Genome Single-stranded DNA, linier, 9.4 kb in size,
infectious, positive sense
Genomic length transcript produce a
precusor polyprotein encoding nonstructural
Replication and protein (replicase, transcriptase)
Proteins
Subgenomic mRNA encodes struktural
protein
Envelope Two glycoproteins
DIRECT DETECTION:
HCV-RNA can be detected in plasma and serum by RT-PCR
Quantity of HCV-RNA
Antigen detection
Detect HCV core antigen in sera by EIA
Genotype (Sequencing of region of the genome)
Based on reverse dot blot hybridization of a PCR amplicon to
nitrocellulose strips coated with genotype-specific probes
HEPATITIS D VIRUS
(DELTA AGENT)
Structure and replication of Hepatitis D virus
Classific Unclassified
ation
Virus Virion 35-37 nm in diameter
Composition RNA
Stability Heat and acid Acid stable Ether Acid sensitive Heat stable Ether sensitive
stable sensitive; acid
sensitive
Transmission Fecal-oral Parenteral Parenteral Parenteral Fecal oral Parenteral
Adapted from Jawetz, Melniek, and Adelberg’s Medical Microbiology. 22th edition
Reference
1. Koziel M.J., Siddiqui A., Hepatitis B Virus and Hepatitis Delta Virus, in: Principles
and Practice of Infectious Disease, 6th ed, Elsevier-Churchill Livingston, p.1864-
1890.
2. Thomas D.L., Ray S.C., Lemon S.M., Hepatitis C, in: Principles and Practice of
Infectious Disease, 6th ed, Elsevier-Churchill Livingston, p.1950-1981.
3. Alter H.J., Hepatitis G and TT Virus, in: Principles and Practice of Infectious
Disease, 6th ed, Elsevier-Churchill Livingston, p.1981-1989.
4. Brooks G.F., Butel J.S., Morse S.A., Hepatitis Viruses, in: Jawetz, Melnick, and
Adelberg’s Medical Microbiology, 22nd ed, Lange-International edition, p. 403-417
5. Mahon C.R., Manuselis G.Jr., Hepatitis Viruses, in: Diagnostic Microbiology,
W.B. Saunders, 1995, p. 812-817.
6. Harvey R.A., Champe P.C., Fisher B.D., Hepatitis B and Hepatitis D (Delta
Viruses), in: Lippincott’s Illustrated Reviews Microbiology, 2nd ed., p. 273-281
TERIMA KASIH